# Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome

> **NCT07182526** · PHASE2 · RECRUITING · sponsor: **Al-Mustansiriyah University** · enrollment: 150 (estimated)

## Conditions studied

- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

## Interventions

- **DRUG:** Quercetin
- **DRUG:** Alpha Lipoic Acid 600 MG Oral Tablet
- **DRUG:** MetFORMIN 500 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT07182526
- **Lead sponsor:** Al-Mustansiriyah University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-20
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182526, "Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07182526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*